|
FAM136A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.554590E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.447800E-01 |
| Normal-vs-Stage2 |
9.703600E-01 |
| Normal-vs-Stage3 |
9.258000E-02 |
| Normal-vs-Stage4 |
2.184100E-02 |
| Stage1-vs-Stage2 |
7.218600E-01 |
| Stage1-vs-Stage3 |
2.037600E-01 |
| Stage1-vs-Stage4 |
4.670100E-02 |
| Stage2-vs-Stage3 |
2.412400E-01 |
| Stage2-vs-Stage4 |
8.847700E-02 |
| Stage3-vs-Stage4 |
4.314200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.438770E-01 |
| Normal-vs-AfricanAmerican |
4.209800E-01 |
| Normal-vs-Asian |
5.923800E-03 |
| Caucasian-vs-AfricanAmerican |
6.142400E-02 |
| Caucasian-vs-Asian |
1.218840E-01 |
| AfricanAmerican-vs-Asian |
5.666300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.794800E-01 |
| Normal-vs-Female |
1.495510E-02 |
| Male-vs-Female |
2.542500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.348200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.200600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.803600E-02 |
| Normal-vs-Age(81-100Yrs) |
6.778200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.304200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.807170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.042400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.131200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.770000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.102600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.428000E-01 |
| Normal-vs-Grade 2 |
1.119590E-01 |
| Normal-vs-Grade 3 |
2.216800E-01 |
| Normal-vs-Grade 4 |
1.429050E-01 |
| Grade 1-vs-Grade 2 |
2.736400E-01 |
| Grade 1-vs-Grade 3 |
3.248000E-01 |
| Grade 1-vs-Grade 4 |
2.054400E-01 |
| Grade 2-vs-Grade 3 |
7.179800E-01 |
| Grade 2-vs-Grade 4 |
8.106200E-01 |
| Grade 3-vs-Grade 4 |
6.128800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.814400E-02 |
| Normal-vs-ccB subtype |
7.978000E-01 |
| ccA subtype-vs-ccB subtype |
8.785800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.916610E-01 |
| Normal-vs-N1 |
5.538200E-02 |
| N0-vs-N1 |
9.576300E-02 |
|
|
